Influenza vaccination rate among patients with moderate to severe psoriasis.
Identifieur interne : 000209 ( Main/Exploration ); précédent : 000208; suivant : 000210Influenza vaccination rate among patients with moderate to severe psoriasis.
Auteurs : Marc Alexander Radtke [Allemagne] ; Stephan Jeff Rustenbach ; Michael Reusch ; Klaus Strömer ; Matthias AugustinSource :
- Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [ 1610-0387 ] ; 2013.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Causalité (MeSH), Comorbidité (MeSH), Enregistrements (MeSH), Facteurs de risque (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Jeune adulte (MeSH), Mâle (MeSH), Prévalence (MeSH), Psoriasis (diagnostic), Psoriasis (épidémiologie), Résultat thérapeutique (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccination (statistiques et données numériques), Vaccins antigrippaux (usage thérapeutique).
- MESH :
- diagnostic : Psoriasis.
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- usage thérapeutique : Vaccins antigrippaux.
- épidémiologie : Allemagne, Grippe humaine, Psoriasis.
- Adulte, Adulte d'âge moyen, Causalité, Comorbidité, Enregistrements, Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Prévalence, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Causality (MeSH), Comorbidity (MeSH), Female (MeSH), Germany (epidemiology), Humans (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), Prevalence (MeSH), Psoriasis (diagnosis), Psoriasis (epidemiology), Registries (MeSH), Risk Factors (MeSH), Treatment Outcome (MeSH), Vaccination (statistics & numerical data), Young Adult (MeSH).
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- diagnosis : Psoriasis.
- epidemiology : Germany, Influenza, Human, Psoriasis.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- Adult, Aged, Aged, 80 and over, Causality, Comorbidity, Female, Humans, Male, Middle Aged, Prevalence, Registries, Risk Factors, Treatment Outcome, Young Adult.
Abstract
BACKGROUND
Patients with chronic inflammatory diseases such as psoriasis vulgaris represent a risk group for developing serious complications after influenza virus infection. By vaccinating this cohort such complications might be prevented. The objective was to determine the vaccination rate among patients with moderate to severe psoriasis and to explore the surrounding circumstances.
PATIENTS AND METHODS
A nationwide, non-interventional, cross-sectional study was performed in 1,229 adults with confirmed psoriasis or psoriatic arthritis. The survey consisting of 15 questions about vaccination and vaccination adherence was distributed to patients enrolled in the psoriasis patient registry "PsoBest".
RESULTS
About 28 % of the patients (95 %-CI 24.0-31.6) were vaccinated. The mean age was 58 years, 40 % were females. The prevalence of psoriatic arthritis was 28 % at baseline and 39 % during the vaccination period. General practitioners vaccinated 50 % of the patients, while dermatologists suggested vaccination in 7 % of the cases. Fifty percent of the patients reported that they had been vaccinated at their own request. 91 % of the patients had been vaccinated at least once over the past ten years, receiving on average 5.9 influenza vaccinations during the decade.
CONCLUSIONS
The vaccination rate in the study cohort was relatively low compared to that in the general population. Influenza vaccination had only been suggested by a small percentage of physicians.
DOI: 10.1111/ddg.12010
PubMed: 23957483
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza vaccination rate among patients with moderate to severe psoriasis.</title><author><name sortKey="Radtke, Marc Alexander" sort="Radtke, Marc Alexander" uniqKey="Radtke M" first="Marc Alexander" last="Radtke">Marc Alexander Radtke</name><affiliation wicri:level="1"><nlm:affiliation>Competence Center Health Services Research in Dermatology - CVderm-, Institute for Health Services Research in Dermatology and Nursing-IVDP, University Clinics, Hamburg Eppendorf, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Competence Center Health Services Research in Dermatology - CVderm-, Institute for Health Services Research in Dermatology and Nursing-IVDP, University Clinics, Hamburg Eppendorf</wicri:regionArea><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion></affiliation></author><author><name sortKey="Rustenbach, Stephan Jeff" sort="Rustenbach, Stephan Jeff" uniqKey="Rustenbach S" first="Stephan Jeff" last="Rustenbach">Stephan Jeff Rustenbach</name></author><author><name sortKey="Reusch, Michael" sort="Reusch, Michael" uniqKey="Reusch M" first="Michael" last="Reusch">Michael Reusch</name></author><author><name sortKey="Stromer, Klaus" sort="Stromer, Klaus" uniqKey="Stromer K" first="Klaus" last="Strömer">Klaus Strömer</name></author><author><name sortKey="Augustin, Matthias" sort="Augustin, Matthias" uniqKey="Augustin M" first="Matthias" last="Augustin">Matthias Augustin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23957483</idno><idno type="pmid">23957483</idno><idno type="doi">10.1111/ddg.12010</idno><idno type="wicri:Area/Main/Corpus">000192</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000192</idno><idno type="wicri:Area/Main/Curation">000192</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000192</idno><idno type="wicri:Area/Main/Exploration">000192</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza vaccination rate among patients with moderate to severe psoriasis.</title><author><name sortKey="Radtke, Marc Alexander" sort="Radtke, Marc Alexander" uniqKey="Radtke M" first="Marc Alexander" last="Radtke">Marc Alexander Radtke</name><affiliation wicri:level="1"><nlm:affiliation>Competence Center Health Services Research in Dermatology - CVderm-, Institute for Health Services Research in Dermatology and Nursing-IVDP, University Clinics, Hamburg Eppendorf, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Competence Center Health Services Research in Dermatology - CVderm-, Institute for Health Services Research in Dermatology and Nursing-IVDP, University Clinics, Hamburg Eppendorf</wicri:regionArea><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion><wicri:noRegion>Hamburg Eppendorf</wicri:noRegion></affiliation></author><author><name sortKey="Rustenbach, Stephan Jeff" sort="Rustenbach, Stephan Jeff" uniqKey="Rustenbach S" first="Stephan Jeff" last="Rustenbach">Stephan Jeff Rustenbach</name></author><author><name sortKey="Reusch, Michael" sort="Reusch, Michael" uniqKey="Reusch M" first="Michael" last="Reusch">Michael Reusch</name></author><author><name sortKey="Stromer, Klaus" sort="Stromer, Klaus" uniqKey="Stromer K" first="Klaus" last="Strömer">Klaus Strömer</name></author><author><name sortKey="Augustin, Matthias" sort="Augustin, Matthias" uniqKey="Augustin M" first="Matthias" last="Augustin">Matthias Augustin</name></author></analytic><series><title level="j">Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</title><idno type="eISSN">1610-0387</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Causality (MeSH)</term><term>Comorbidity (MeSH)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Prevalence (MeSH)</term><term>Psoriasis (diagnosis)</term><term>Psoriasis (epidemiology)</term><term>Registries (MeSH)</term><term>Risk Factors (MeSH)</term><term>Treatment Outcome (MeSH)</term><term>Vaccination (statistics & numerical data)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Causalité (MeSH)</term><term>Comorbidité (MeSH)</term><term>Enregistrements (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Prévalence (MeSH)</term><term>Psoriasis (diagnostic)</term><term>Psoriasis (épidémiologie)</term><term>Résultat thérapeutique (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccins antigrippaux (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Germany</term><term>Influenza, Human</term><term>Psoriasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Grippe humaine</term><term>Psoriasis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Causality</term><term>Comorbidity</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prevalence</term><term>Registries</term><term>Risk Factors</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Causalité</term><term>Comorbidité</term><term>Enregistrements</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Prévalence</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Patients with chronic inflammatory diseases such as psoriasis vulgaris represent a risk group for developing serious complications after influenza virus infection. By vaccinating this cohort such complications might be prevented. The objective was to determine the vaccination rate among patients with moderate to severe psoriasis and to explore the surrounding circumstances.</p></div><div type="abstract" xml:lang="en"><p><b>PATIENTS AND METHODS</b></p><p>A nationwide, non-interventional, cross-sectional study was performed in 1,229 adults with confirmed psoriasis or psoriatic arthritis. The survey consisting of 15 questions about vaccination and vaccination adherence was distributed to patients enrolled in the psoriasis patient registry "PsoBest".</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>About 28 % of the patients (95 %-CI 24.0-31.6) were vaccinated. The mean age was 58 years, 40 % were females. The prevalence of psoriatic arthritis was 28 % at baseline and 39 % during the vaccination period. General practitioners vaccinated 50 % of the patients, while dermatologists suggested vaccination in 7 % of the cases. Fifty percent of the patients reported that they had been vaccinated at their own request. 91 % of the patients had been vaccinated at least once over the past ten years, receiving on average 5.9 influenza vaccinations during the decade.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>The vaccination rate in the study cohort was relatively low compared to that in the general population. Influenza vaccination had only been suggested by a small percentage of physicians.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23957483</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1610-0387</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</Title><ISOAbbreviation>J Dtsch Dermatol Ges</ISOAbbreviation></Journal><ArticleTitle>Influenza vaccination rate among patients with moderate to severe psoriasis.</ArticleTitle><Pagination><MedlinePgn>837-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ddg.12010</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with chronic inflammatory diseases such as psoriasis vulgaris represent a risk group for developing serious complications after influenza virus infection. By vaccinating this cohort such complications might be prevented. The objective was to determine the vaccination rate among patients with moderate to severe psoriasis and to explore the surrounding circumstances.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A nationwide, non-interventional, cross-sectional study was performed in 1,229 adults with confirmed psoriasis or psoriatic arthritis. The survey consisting of 15 questions about vaccination and vaccination adherence was distributed to patients enrolled in the psoriasis patient registry "PsoBest".</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">About 28 % of the patients (95 %-CI 24.0-31.6) were vaccinated. The mean age was 58 years, 40 % were females. The prevalence of psoriatic arthritis was 28 % at baseline and 39 % during the vaccination period. General practitioners vaccinated 50 % of the patients, while dermatologists suggested vaccination in 7 % of the cases. Fifty percent of the patients reported that they had been vaccinated at their own request. 91 % of the patients had been vaccinated at least once over the past ten years, receiving on average 5.9 influenza vaccinations during the decade.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The vaccination rate in the study cohort was relatively low compared to that in the general population. Influenza vaccination had only been suggested by a small percentage of physicians.</AbstractText><CopyrightInformation>© The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radtke</LastName><ForeName>Marc Alexander</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Competence Center Health Services Research in Dermatology - CVderm-, Institute for Health Services Research in Dermatology and Nursing-IVDP, University Clinics, Hamburg Eppendorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rustenbach</LastName><ForeName>Stephan Jeff</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Reusch</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Strömer</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Augustin</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Dtsch Dermatol Ges</MedlineTA><NlmUniqueID>101164708</NlmUniqueID><ISSNLinking>1610-0379</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011565" MajorTopicYN="N">Psoriasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="Y">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>11</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23957483</ArticleId><ArticleId IdType="doi">10.1111/ddg.12010</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country></list><tree><noCountry><name sortKey="Augustin, Matthias" sort="Augustin, Matthias" uniqKey="Augustin M" first="Matthias" last="Augustin">Matthias Augustin</name><name sortKey="Reusch, Michael" sort="Reusch, Michael" uniqKey="Reusch M" first="Michael" last="Reusch">Michael Reusch</name><name sortKey="Rustenbach, Stephan Jeff" sort="Rustenbach, Stephan Jeff" uniqKey="Rustenbach S" first="Stephan Jeff" last="Rustenbach">Stephan Jeff Rustenbach</name><name sortKey="Stromer, Klaus" sort="Stromer, Klaus" uniqKey="Stromer K" first="Klaus" last="Strömer">Klaus Strömer</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Radtke, Marc Alexander" sort="Radtke, Marc Alexander" uniqKey="Radtke M" first="Marc Alexander" last="Radtke">Marc Alexander Radtke</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000209 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000209 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23957483
|texte= Influenza vaccination rate among patients with moderate to severe psoriasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23957483" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |